Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor β gene in human colon carcinoma cells

Anti-Cancer Drugs

Volumn 9, Issue 9, 1998, Pages 743-750

  Côté, Sylvie ^a   Sinnett, Daniel ^a   Momparler, Richard L ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

5 Aza 2' deoxycytidine; Colon cancer; DNA methylation; Retinoic acid receptor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; 5 METHYLCYTOSINE; PYRIMIDINE ANTAGONIST; RETINOIC ACID RECEPTOR;

ARTICLE; CPG ISLAND; DEMETHYLATION; DNA SEQUENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; TUMOR CELL LINE;

EID: 0031731906     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199810000-00001     Document Type: Article

References (46)

1. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-70.
2. Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359: 235-7.
3. Risio M, Reato G, di Celle PF, Fizzotti M, Rossini FP, Foà R. Microsatellite instability is associated with the histological features of the tumor in nonfamilial colorectal cancer. Cancer Res 1996; 56: 5470-4.
4. Pretlow TP, Brasitus TA, Fulton NC, Cheyer C, Kaplan, EL. K-ras mutations in putative preneoplastic lesions in human colon. J Natl Cancer Inst 1993; 85: 2004-7.
5. Rodrigues NR, Rowan A, Smith MEF, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990; 87: 7555-9.
6. Jones PA. DNA methylation errors and cancer. Cancer Res 1996; 56: 2463-7
7. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa J-PJ. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72: 141-96.
8. Hug M, Silke J, Georgiev O, Rusconi S, Schaffner W, Matsuo K. Transcriptional repression by methylation cooperativity between a CpG cluster in the promoter and remote CpG-rich regions. FEBS Lett 1996; 379: 251-4.
9. Eden S, Cedar H. Role of DNA methylation in the regulation of transcription. Curr Opin Genet Dev 1994; 4: 255-
10. Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995; 55: 4525-30.
11. Kane MF, Loda M, Gaida GM, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997; 57: 808-11.
12. Ahuja N, Mohan AL, Li Q, et al. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res 1997; 57: 3370-4.
13. Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor gene p16/CDKN2/MTS1 in human cancers. Nat Med 1995; 1: 686-92.
14. Gonzalez-Zulueta M, Bender CM, Yang AS, et al. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995; 55: 4531-5.
15. Greger V, Debus N, Lohmann D, Höpping W, Passarge E, Horsthemke B. Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet 1994; 94: 491-6.
16. Herman JG, Latif F, Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994; 91: 9700-4.
17. Dobrovic A, Simpfendorfer D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 1997; 57: 3347-50.
18. Huynh H, Alpert L, Pollak M. Silencing of the mammary-derived growth inhibitor (MDGI) gene in breast neoplasms is associated with epigenetic changes. Cancer Res 1996; 56: 4865-70.
19. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 1995; 92: 7416-9.
20. Qian XC, Brent TP. Methylation hot spots in the 5′ flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene. Cancer Res 1997; 57: 3672-7.
21. Sporn MB, Roberts AB. Role of retinoids in differentiation and carcinogenesis. Cancer Res 1983; 43: 3034-40.
22. Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS, eds. The retinoids, 2nd edn. Orlando, FL: Academic Press 1994: 319-49.
23. Houle B, Rochette-Egly C, Bradley WEC. Tumor-suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc Natl Acad Sci USA 1993; 90: 985-9.
24. Houle B, Leduc F, Bradley WEC. Implication of RARβ in epidermoid (squamous) lung cancer. Genes Chromosomes Cancer 1991; 3: 358-66.
25. Hung J, Kishimoto Y, Sugio K, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J Am Med Ass 1995; 273: 558-63.
26. Zhang X-K, Liu Y, Lee M-O, Pfahl M. A specific defect in the retinoic acid receptor associated with human lung cancer cell lines. Cancer Res 1994; 54: 5663-9.
27. Xu X-C, Sozzi G, Lee JS, et al. Suppression of retinoic acid receptor β in non-small-cell lung cancer in vivo: implications for lung cancer development. J Natl Cancer Inst 1997; 89: 624-9.
28. Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res 1991; 51: 3972-81.
29. Xu X-C, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 1994; 54: 3580-7.
30. Swisshelm K, Ryan K, Lee X, Tsou HC, Peacocke M, Sager R. Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ 1994; 5: 133-41.
31. Geisen C, Denk C, Gremm B, et al. High-level expression of the retinoic acid receptor β gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor a and abnormally down-regulated in cervical carcinoma cells. Cancer Res 1997; 57: 1460-7.
32. Calario MJ, Marmouget C, Guichard S, et al. Response of four human ovarian carcinoma cell lines to all-trans retinoic acid: relationship with induction of differentiation and retinoic acid receptor expression. Int J Cancer 1994; 56: 743-8.
33. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K. Expression of retinoic acid receptor β mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Different 1995; 6: 1077-88.
34. 2 transgene. FASEB J 1996; 10: 1091-7.
35. Côté S, Momparler RL. Activation of the retinoic acid receptor β gene by 5-Aza-2′-deoxycytidine in human DLD-1 colon carcinoma cells. Anti-Cancer Drugs 1997; 8: 56-61.
36. Côté S, Momparler RL. Antineoplastic action of all-trans retinoic acid and 5-Aza-2′-deoxycytidine on human DLD-1 colon carcinoma cells. Cell Pharmacol 1995; 2: 221-8.
37. Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992; 89: 1827-31.
38. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-6.
39. 2 promo ters: sequence comparison and localization of retinoic acid responsiveness. J DNA Sequencing and Mapping 1991; 2: 111-9.
40. Zelent A, Mendelsohn C, Kastner P, et al. Differentially expressed isoforms of the mouse retinoic acid receptor β are generated by usage of two promoters and alternative splicing. EMRO J 1991; 10: 71-81.
41. Comb M, Goodman HM. CpG methylation inhibits proenkephalin gene expression and the binding of the transcription factor AP2. Nucleic Acids Res 1990; 18: 3975-82.
42. Christman JK. DNA methylation in Friend erythroleukemia cells: the effects of chemically induced differentiation and of treatment with inhibitors of DNA methylation. Curr Top Microbial Immunol 1984; 108: 49-78.
43. Widschwendter M, Berger J, Daxenbichler G, et al. Loss of retinoic acid receptor β expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res 1997; 57: 4158-61.
44. Issa J-PJ, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536-40.
45. Baccichet A, Benachenhou N, Couture F, Leclerc J-M, Sinnett D. Microsatellite instability in childhood T cell acute lymphoblastic leukemia. Leukemia 1997; 11: 797-802.
46. Momparler RL, Bouffard DY, Momparler LF, Dionne J, Bélanger K, Ayoub J. Pilot phase I-II study on 5-aza-2′-deoxycytidine (Decitabine) in patients with metastatic lung cancer. Anti-Cancer Drugs 1997; 8: 358-68.